Hs-CRP and HOMA-IR: Include them in the MASLD definition, or treat them as mediators between MASLD and atherosclerotic cardiovascular disease?
Heng Wan(The First People's Hospital of Shunde), Jie Shen(Xinjiang Medical University), Ningjian Wang(Second Military Medical University), Lan Liu(Sanjiang University), Zihao Gui(The First People's Hospital of Shunde)
Cited by 14
Related Papers
Camrelizumab in Combination with Apatinib in Patients with Advanced Hepatocellular Carcinoma (RESCUE): A Nonrandomized, Open-label, Phase II Trial
|Clinical Cancer Research|2020|576
<p>Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomes Combined Pluronic F127 Hydrogel Promote Chronic Diabetic Wound Healing and Complete Skin Regeneration</p>
|International Journal of Nanomedicine|2020|521
Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease
|Diabetes Care|2012|365
Causal associations of short and long sleep durations with 12 cardiovascular diseases: linear and nonlinear Mendelian randomization analyses in UK Biobank
|European Heart Journal|2021|261
Long-term night shift work is associated with the risk of atrial fibrillation and coronary heart disease
|European Heart Journal|2021|213